Letter to the Editor: Hepatocellular Carcinoma Surveillance in Cirrhosis Patients: Is the Real‐World Situation Even Worse Than Reported?
Daniel Q. Huang, Yee Hui Yeo, Mindie H. Nguyen – 21 February 2021
Gene Deconvolution Reveals Aberrant Liver Regeneration and Immune Cell Infiltration in Alcohol‐Associated Hepatitis
Adam Kim, Xiaoqin Wu, Daniela S. Allende, Laura E. Nagy – 21 February 2021
Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET‐NASH Study
A. Sidney Barritt, Stephanie Watkins, Norman Gitlin, Samuel Klein, Anna S. Lok, Rohit Loomba, Cheryl Schoen, K. Rajender Reddy, Huy Ngoc Trinh, Andrea R. Mospan, Miriam B. Vos, L. Michael Weiss, Kenneth Cusi, Brent A. Neuschwander‐Tetri, Arun J. Sanyal – 20 February 2021 – Much of the current data on nonalcoholic fatty liver disease (NAFLD) are derived from biopsy‐based studies that may introduce ascertainment and selection bias. Selection of patients for liver biopsy has implications for clinical practice and the reported epidemiology of NAFLD.
Characterization of Acute HCV Infection and Transmission Networks in People Who Currently Inject Drugs in Catalonia: Usefulness of Dried Blood Spots
Adrián Antuori, Vincent Montoya, David Piñeyro, Lauro Sumoy, Jeffrey Joy, Mel Krajden, Sara González‐Gómez, Cinta Folch, Jordi Casabona, Lurdes Matas, Joan Colom, Verónica Saludes, Elisa Martró, HepCdetect II Study Group – 19 February 2021
Myofibroblast‐Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model
Chen Qu, Lu He, Nan Yao, Jinying Li, Yuchuan Jiang, Binkui Li, Shuang Peng, Kunpeng Hu, Dong Chen, Guo Chen, Wei Huang, Mingrong Cao, Jun Fan, Yunfei Yuan, Wencai Ye, Jian Hong – 19 February 2021
County‐Level Variation in Hepatitis C Virus Mortality and Trends in the United States, 2005‐2017
Eric W. Hall, Sarah Schillie, Adam S. Vaughan, Jeb Jones, Heather Bradley, Ben Lopman, Eli S. Rosenberg, Patrick S. Sullivan – 19 February 2021
Microbiota‐Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling
Fanta Barrow, Saad Khan, Gavin Fredrickson, Haiguang Wang, Katrina Dietsche, Preethy Parthiban, Sacha Robert, Thomas Kaiser, Shawn Winer, Adam Herman, Oyedele Adeyi, Marialena Mouzaki, Alexander Khoruts, Kristin A. Hogquist, Christopher Staley, Daniel A. Winer, Xavier S. Revelo – 19 February 2021
Reply
Deniz Balci – 19 February 2021
Serum Laminin γ2 Monomer as a Diagnostic and Predictive Biomarker for Hepatocellular Carcinoma
Taro Yamashita, Naohiko Koshikawa, Tetsuro Shimakami, Takeshi Terashima, Masatoshi Nakagawa, Kouki Nio, Rika Horii, Noriho Iida, Kazunori Kawaguchi, Kuniaki Arai, Yoshio Sakai, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Azusa Kitao, Satoshi Kobayashi, Shizuko Takahara, Yasuhito Imai, Kenichi Yoshimura, Toshinori Murayama, Yasunari Nakamoto, Eisaku Yoshida, Toru Yoshimura, Motoharu Seiki, Shuichi Kaneko – 19 February 2021
Cardiac Risk Stratification in Liver Transplantation: Results of a Tiered Assessment Protocol Based on Traditional Cardiovascular Risk Factors
Marcus Robertson, William Chung, Dorothy Liu, Rosemary Seagar, Tess O’Halloran, Anoop N. Koshy, Mark Horrigan, Omar Farouque, Paul Gow, Peter Angus – 18 February 2021 – Coronary artery disease (CAD) confers increased perioperative risk in patients undergoing liver transplantation (LT). Although routine screening for CAD is recommended, there are limited data on the effectiveness of screening strategies. We evaluated the safety and efficacy of a 3‐tiered cardiac risk‐assessment protocol that stratifies patients based on age and traditional cardiac risk factors.